MedTech Business Devyser and Thermo Fisher Scientific expand collaboration Malin Otmani September 6, 2023
Financing Moberg Pharma is recommended EU approval and proposes a rights issue Malin Otmani June 28, 2023
New Market 170 Views China NMPA’s approves Calliditas’ Nefecon Malin Otmani November 27, 2023 Calliditas’ partner Everest Medicines has…
Biotech Business 362 Views New company aims to redefine cell therapy development Malin Otmani October 2, 2023 Alder Therapeutics is a newly…
New Market 331 Views Orexo submits New Drug Application to FDA Malin Otmani September 19, 2023 Orexo has announced the submission…
MedTech Business 2682 Views Devyser and Thermo Fisher Scientific expand collaboration Malin Otmani September 6, 2023 Devyser and Thermo Fisher Scientific…
MedTech Business 2624 Views Senzime receives its largest US order to date Malin Otmani September 6, 2023 Senzime has announces an initial…
New Market 364 Views AstraZeneca’s Calquence approved in China Malin Otmani September 4, 2023 Calquence, a next generation, selective…
MedTech Business 2943 Views Episurf’s first commercial case in the US scheduled Malin Otmani August 23, 2023 Episurf Medical has announced that…
MedTech Business 4264 Views Devyser has inaugurated its CLIA-certified laboratory Malin Otmani July 5, 2023 The new laboratory in Atlanta,…
Financing 622 Views Moberg Pharma is recommended EU approval and proposes a rights issue Malin Otmani June 28, 2023 The company has announced that…
New Market 422 Views AstraZeneca’s Xigduo XR approved in China Malin Otmani June 27, 2023 Xigduo XR, a once-daily fixed-dose…
New Market 303 Views AstraZeneca’s Soliris recommended for approval in the EU Malin Otmani June 26, 2023 Soliris has been recommended for…
Agreement 4711 Views InDex Pharmaceuticals enters license agreement with Viatris Japan Malin Otmani June 2, 2023 InDex Pharmaceuticals has announced that…
New Market 608 Views AstraZeneca’s Ultomiris approved in the EU Malin Otmani May 15, 2023 Ultomiris has been approved in…
Biotech Business 5925 Views AstraZeneca’s Koselugo approved in China Malin Otmani May 10, 2023 Koselugo (selumetinib) has been approved…
Biotech Business 6771 Views STADA and Xbrane launch ranibizumab in Europe Malin Otmani April 5, 2023 Ranibizumab biosimilar is being launched…
New Market 1220 Views AstraZeneca’s Calquence granted first regulatory approval in China Malin Otmani March 27, 2023 Calquence, a next generation, selective…